MARKET

GRN

GRN

iPath® Series B Carbon ETN
NYSEARCA
24.25
-0.16
-0.66%
Closed 15:48 03/27 EDT
OPEN
23.99
PREV CLOSE
24.41
HIGH
24.35
LOW
23.92
VOLUME
3.36K
TURNOVER
0
52 WEEK HIGH
38.24
52 WEEK LOW
20.09
TOTAL ASSET
90.22M
YTD YIELD
-29.07%
1D
5D
1M
3M
1Y
5Y
Earnings Scheduled For March 26, 2024
Bluebird bio is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. AIM ImmunoTech is estimated to report earnings for its fourth quarter. Elbit Systems is projected to report. Quarterly earnings at $1.38 per share.
Benzinga · 2d ago
Weekly Report: what happened at GRN last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at GRN last week (0311-0315)?
Weekly Report · 03/18 12:00
A Vote For Value Stocks In 2024
Seeking Alpha · 03/15 08:20
Weekly Report: what happened at GRN last week (0304-0308)?
Weekly Report · 03/11 11:55
Weekly Report: what happened at GRN last week (0226-0301)?
Weekly Report · 03/04 11:59
Weekly Report: what happened at GRN last week (0219-0223)?
Weekly Report · 02/26 12:17
Weekly Report: what happened at GRN last week (0212-0216)?
Weekly Report · 02/19 12:19
More
Profile
Fund Name
iPath® Series B Carbon ETN
Inception Date
2019-09-10
Benchmark
Barclays Gbl Carbon TR USD
Advisor Company
Barclays Bank PLC
Custodian
Barclays Bank PLC
Manager
No Manager